158 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Pickel TC, Pashikanti G, Voll RJ, Yu W, Zhang Z, Nye JA, Bacsa J, Olson JJ, Liebeskind LS, Goodman MM. Synthesis, Radiolabeling, and Biological Evaluation of the -Stereoisomers of 1-Amino-3-(fluoro-F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents. Acs Pharmacology & Translational Science. 4: 1195-1203. PMID 34151209 DOI: 10.1021/acsptsci.1c00062  0.337
2020 Pickel T, Voll RJ, Yu W, Zhang Z, Nye J, Bacsa J, Olson JJ, Liebeskind LS, Goodman MM. Synthesis, Radiolabeling, and Biological Evaluation of the Cis Stereoisomers of 1-amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic acid as PET Imaging Agents. Journal of Medicinal Chemistry. PMID 32946235 DOI: 10.1021/Acs.Jmedchem.0C01302  0.452
2020 Stehouwer JS, Birnbaum MS, Voll RJ, Owens MJ, Plott SJ, Bourke CH, Wassef MA, Kilts CD, Goodman MM. Erratum to "Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor" [Bioorg. Med. Chem. 23 (2015) 4286-4302]. Bioorganic & Medicinal Chemistry. 115660. PMID 32747078 DOI: 10.1016/j.bmc.2020.115660  0.535
2020 Alemozaffar M, Akintayo AA, Abiodun-Ojo OA, Patil D, Saeed F, Huang Y, Osunkoya AO, Goodman MM, Sanda M, Schuster DM. [F]fluciclovine PET/CT for Preoperative Staging in Patients with Intermediate to High-Risk Primary Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 32347780 DOI: 10.1097/JU.0000000000001095  0.341
2019 Oum YH, Shetty D, Yoon Y, Liang Z, Voll RJ, Goodman MM, Shim H. A benzenesulfonamide derivative as a novel PET radioligand for CXCR4. Bioorganic & Medicinal Chemistry. 115240. PMID 31843463 DOI: 10.1016/J.Bmc.2019.115240  0.399
2019 Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo OO, Tade FI, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Fei B, Schuster DM. F-Fluciclovine parameters on targeted prostate biopsy associated with true positivity in recurrent prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30954940 DOI: 10.2967/jnumed.119.227033  0.309
2019 Fei B, Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo O, Tade F, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Schuster DM. Feasibility and Initial Results: Fluciclovine PET/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 30817240 DOI: 10.1097/JU.0000000000000200  0.319
2018 Parent EE, Benayoun M, Ibeanu I, Olson JJ, Hadjipanayis CG, Brat DJ, Adhikarla V, Nye J, Schuster DM, Goodman MM. [F]Fluciclovine PET discrimination between high- and low-grade gliomas. Ejnmmi Research. 8: 67. PMID 30046944 DOI: 10.1186/S13550-018-0415-3  0.377
2018 Tade FI, Wiles WG, Lu G, Bilir B, Akin-Akintayo O, Lee JS, Patil D, Yu W, Ormenisan Gherasim C, Fei B, Moreno CS, Osunkoya AO, Teoh EJ, Oka S, Okudaira H, ... Goodman MM, et al. Selective modification of fluciclovine (F) transport in prostate carcinoma xenografts. Amino Acids. PMID 29905905 DOI: 10.1007/s00726-018-2600-0  0.396
2018 Akin-Akintayo O, Tade F, Mittal P, Moreno C, Nieh PT, Rossi P, Patil D, Halkar R, Fei B, Master V, Jani AB, Kitajima H, Osunkoya AO, Ormenisan-Gherasim C, Goodman MM, et al. Prospective evaluation of fluciclovine (F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients. European Journal of Radiology. 102: 1-8. PMID 29685521 DOI: 10.1016/j.ejrad.2018.02.006  0.349
2018 Zeng F, Nye JA, Voll RJ, Howell L, Goodman MM. Synthesis and Evaluation of Pyridyloxypyridyl Indole Carboxamides as Potential PET Imaging Agents for 5-HTReceptors. Acs Medicinal Chemistry Letters. 9: 188-192. PMID 29541358 DOI: 10.1021/Acsmedchemlett.7B00443  0.36
2017 Lipowska M, Jarkas N, Voll RJ, Nye JA, Klenc J, Goodman MM, Taylor AT. Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation. Nuclear Medicine and Biology. 58: 42-50. PMID 29367095 DOI: 10.1016/J.Nucmedbio.2017.12.001  0.369
2017 Pippin AB, Voll RJ, Li Y, Wu H, Mao H, Goodman MM. Radiochemical Synthesis and Evaluation of 13N-Labeled 5-Aminolevulinic Acid for PET Imaging of Gliomas. Acs Medicinal Chemistry Letters. 8: 1236-1240. PMID 29259740 DOI: 10.1021/Acsmedchemlett.7B00311  0.399
2017 Goodman MM, Yu W, Jarkas N. Synthesis and Biological Properties of Radiohalogenated α,α-Disubstituted Amino Acids for PET and SPECT Imaging of Amino Acid Transporters (AATs). Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29143354 DOI: 10.1002/jlcr.3584  0.395
2017 Adhikarla V, Dunlop BW, Jarkas N, Goodman M, Mayberg H, Owens MJ, Nye JA. Test-retest reliability of the SERT imaging agent [(11)C]HOMADAM in healthy humans. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28935840 DOI: 10.2967/Jnumed.117.196915  0.556
2017 Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H. PET Tracer (18)F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models. Theranostics. 7: 2048-2064. PMID 28656060 DOI: 10.7150/thno.19883  0.326
2017 Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H. Fasting Enhances the Contrast of Bone Metastatic Lesions in (18)F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases. International Journal of Molecular Sciences. 18. PMID 28468238 DOI: 10.3390/ijms18050934  0.383
2017 Zanoni L, Nanni C, Bach-Gansmo T, Bogsrud TV, Nieh P, Kieboom J, Korsan KA, Sletten H, Tade FI, Odewole O, Ward P, Chau A, Goodman M, Fanti S, Schuster DM, et al. Multisite experience of fluciclovine (18F) PET/CT imaging in biochemically recurrent prostate cancer: Impact of clinical factors and intersite variation. Journal of Clinical Oncology. 35: 163-163. DOI: 10.1200/Jco.2017.35.6_Suppl.163  0.328
2017 Akin-Akintayo O, Tade F, Mittal P, Moreno C, Nieh P, Rossi P, Raghuveer H, Fei B, Goodman M, Schuster D. MP18-08 COMPARISON OF FLUCICLOVINE (18F) PET-CT AND MRI IN DETECTION OF RECURRENT PROSTATE CANCER Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.618  0.34
2016 Bach-Gansmo T, Nanni C, Nieh PT, Zanoni L, Bogsrud TV, Sletten H, Korsan K, Kieboom J, Tade F, Odewole O, Chau A, Ward P, Goodman MM, Fanti S, Schuster DM, et al. Multi-site experience of the safety, detection rate and diagnostic performance of fluciclovine ((18)F) PET/CT imaging in the staging of biochemically recurrent prostate cancer. The Journal of Urology. PMID 27746282 DOI: 10.1016/j.juro.2016.09.117  0.351
2016 Bach-Gansmo T, Nanni C, Nieh P, Zanoni L, Bogsrud T, Sletten H, Korsan K, Kieboom J, Chau A, Ward P, Willoch F, Goodman M, Fanti S, Schuster DM. Staging of Biochemically Relapsing Prostate Cancer Using the Positron Emission Tomography Tracer Fluciclovine F18. International Journal of Radiation Oncology, Biology, Physics. 96: S112. PMID 27675555 DOI: 10.1016/j.ijrobp.2016.06.275  0.34
2016 Jani A, Schreibmann E, Rossi PJ, Shelton JW, Godette K, Nieh P, Master VA, Kucuk O, Goodman M, Halkar R, Cooper S, Chen Z, Schuster DM. Impact of Fluciclovine (18F) Positron Emission Tomography on Target Volume Definition for Post-Prostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27609792 DOI: 10.2967/Jnumed.116.176057  0.389
2016 Pippin AB, Mohd Arshad ZH, Voll RJ, Nye JA, Ghassabian S, Williams CM, Mancini A, Liotta DC, Smith MT, Goodman MM. In Vitro Metabolic Stability and in Vivo Biodistribution of 3-Methyl-4-furoxancarbaldehyde Using PET Imaging in Rats. Acs Medicinal Chemistry Letters. 7: 563-7. PMID 27326327 DOI: 10.1021/Acsmedchemlett.5B00410  0.332
2016 Smith AL, Freeman SM, Barnhart TE, Abbott DH, Ahlers EO, Kukis DL, Bales KL, Goodman MM, Young LJ. Initial investigation of three selective and potent small molecule oxytocin receptor PET ligands in New World monkeys. Bioorganic & Medicinal Chemistry Letters. PMID 27209233 DOI: 10.1016/J.Bmcl.2016.04.097  0.391
2016 Adhikarla V, Zeng F, Votaw JR, Goodman MM, Nye JA. Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain. Nuclear Medicine and Biology. 43: 318-23. PMID 27150035 DOI: 10.1016/J.Nucmedbio.2016.02.008  0.403
2016 Odewole OA, Tade FI, Nieh PT, Savir-Baruch B, Jani AB, Master VA, Rossi PJ, Halkar RK, Osunkoya AO, Akin-Akintayo O, Zhang C, Chen Z, Goodman MM, Schuster DM. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27091135 DOI: 10.1007/S00259-016-3383-8  0.36
2016 Tade FI, Cohen MA, Styblo TM, Odewole OA, Holbrook AI, Newell MS, Savir-Baruch B, Li XB, Goodman MM, Nye JA, Schuster DM. Anti-3-[18F] FACBC (Fluciclovine) PET-CT of Breast Cancer An Exploratory Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27056619 DOI: 10.2967/Jnumed.115.171389  0.39
2016 Bogsrud TV, Nanni C, Nieh P, Zanoni L, Bach-Gansmo T, Sletten H, Koren K, Kieboom J, Chau A, Ward P, Goodman M, Fanti S, Schuster D, Willoch F. Mp79-19 Impact Of Intrinsic And Extrinsic Factors On The Detection Rate Of The Pet Tracer Fluciclovine (18F) In Biochemical Relapse Of Prostate Cancer: A Multi-Institutional Experience The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2017  0.341
2015 Okudaira H, Nakanishi T, Oka S, Kobayashi M, Tamagami H, Schuster DM, Goodman MM, Shirakami Y, Tamai I, Kawai K. Corrigendum to "Kinetic analyses of trans-1-amino-3-[F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2" (Nucl. Med. Biol. 2013;40:670-675). Nuclear Medicine and Biology. 42: 513-514. PMID 29609828 DOI: 10.1016/j.nucmedbio.2014.12.013  0.328
2015 Stehouwer JS, Bourke CH, Owens MJ, Voll RJ, Kilts CD, Goodman MM. Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors. Bioorganic & Medicinal Chemistry Letters. 25: 5111-4. PMID 26456805 DOI: 10.1016/j.bmcl.2015.10.010  0.62
2015 Stehouwer JS, Goodman MM. Preparation of 1-Tosyloxy-4-Substituted-2-butenes Using Ag(I) Salts. Tetrahedron Letters. 56: 4480-4482. PMID 26309335 DOI: 10.1016/j.tetlet.2015.05.100  0.336
2015 Ono M, Oka S, Okudaira H, Nakanishi T, Mizokami A, Kobayashi M, Schuster DM, Goodman MM, Shirakami Y, Kawai K. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells. Nuclear Medicine and Biology. 42: 887-92. PMID 26278491 DOI: 10.1016/j.nucmedbio.2015.07.005  0.398
2015 Stehouwer JS, Birnbaum MS, Voll RJ, Owens MJ, Plott SJ, Bourke CH, Wassef MA, Kilts CD, Goodman MM. Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor. Bioorganic & Medicinal Chemistry. PMID 26145817 DOI: 10.1016/j.bmc.2015.06.036  0.59
2015 Yu W, McConathy J, Olson JJ, Goodman MM. System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid. Nuclear Medicine and Biology. 42: 8-18. PMID 25263130 DOI: 10.1016/j.nucmedbio.2014.07.002  0.679
2015 Jani A, Schreibmann E, Rossi PJ, Shelton JW, Godette KD, Nieh P, Master VA, Kucuk O, Goodman M, Halkar R, Cooper S, Chen Z, Schuster DM. Impact of Anti-3-[18F]FACBC Positron Emission Tomography on Target Volume Definition After Prostatectomy: Initial Findings From a Randomized Trial International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.322  0.354
2015 Schreibmann E, Schuster DM, Rossi PJ, Shelton JW, Cooper S, Goodman M, Halkar R, Funmilayo T, Odewole O, Jani A. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC Positron Emission Tomography: Workflow and Initial Findings International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1966  0.359
2014 Schuster DM, Nanni C, Fanti S, Oka S, Okudaira H, Inoue Y, Sörensen J, Owenius R, Choyke P, Turkbey B, Bogsrud TV, Bach-Gansmo T, Halkar RK, Nye JA, Odewole OA, ... ... Goodman MM, et al. Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1986-92. PMID 25453047 DOI: 10.2967/Jnumed.114.143628  0.423
2014 Ning X, Seo W, Lee S, Takemiya K, Rafi M, Feng X, Weiss D, Wang X, Williams L, Camp VM, Eugene M, Taylor WR, Goodman M, Murthy N. PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angewandte Chemie (International Ed. in English). 53: 14096-101. PMID 25330976 DOI: 10.1002/Anie.201408533  0.392
2014 Okudaira H, Oka S, Ono M, Nakanishi T, Schuster DM, Kobayashi M, Goodman MM, Tamai I, Kawai K, Shirakami Y. Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 756-64. PMID 24943499 DOI: 10.1007/s11307-014-0756-x  0.386
2014 Nye JA, Votaw JR, Bremner JD, Davis MR, Voll RJ, Camp VM, Goodman MM. Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans. Nuclear Medicine and Biology. 41: 217-22. PMID 24533985 DOI: 10.1016/J.Nucmedbio.2013.12.013  0.383
2014 Schuster DM, Nieh PT, Jani AB, Amzat R, Bowman FD, Halkar RK, Master VA, Nye JA, Odewole OA, Osunkoya AO, Savir-Baruch B, Alaei-Taleghani P, Goodman MM. Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. The Journal of Urology. 191: 1446-53. PMID 24144687 DOI: 10.1016/J.Juro.2013.10.065  0.367
2014 Oka S, Okudaira H, Ono M, Schuster DM, Goodman MM, Kawai K, Shirakami Y. Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 322-9. PMID 24136390 DOI: 10.1007/s11307-013-0693-0  0.409
2014 Howell L, Nye J, Stehouwer J, Voll R, Mun J, Narasimhan D, Nichols J, Sunahara R, Goodman M, Carroll F, Woods J. Effects of a mutant bacterial cocaine esterase on cocaine brain levels measured with pet neuroimaging in rhesus monkeys Drug and Alcohol Dependence. 140: e92-e93. DOI: 10.1016/J.Drugalcdep.2014.02.269  0.313
2013 Zeng F, Voll RJ, Crowe RJ, Waldrep MS, Dolph KB, Goodman MM. An improved synthesis of [11C]MENET via Suzuki coupling with [11C]methyl iodide. Journal of Labelled Compounds & Radiopharmaceuticals. 56: 307-9. PMID 24285377 DOI: 10.1002/jlcr.3047  0.303
2013 Stehouwer JS, Goodman MM. (11) C and (18) F PET radioligands for the serotonin transporter (SERT). Journal of Labelled Compounds & Radiopharmaceuticals. 56: 114-9. PMID 24285317 DOI: 10.1002/jlcr.3011  0.44
2013 Jarkas N, Voll RJ, Goodman MM. Synthesis of a phenolic precursor and its efficient O-[18F]fluoroethylation with purified no-carrier-added [18F]2-fluoroethyl brosylate as the labeling agent. Journal of Labelled Compounds & Radiopharmaceuticals. 56: 539-43. PMID 24285185 DOI: 10.1002/jlcr.3046  0.369
2013 Ono M, Oka S, Okudaira H, Schuster DM, Goodman MM, Kawai K, Shirakami Y. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines. Brain Research. 1535: 24-37. PMID 23994214 DOI: 10.1016/j.brainres.2013.08.037  0.386
2013 Smith AL, Freeman SM, Voll RJ, Young LJ, Goodman MM. Investigation of an F-18 oxytocin receptor selective ligand via PET imaging. Bioorganic & Medicinal Chemistry Letters. 23: 5415-20. PMID 23978650 DOI: 10.1016/J.Bmcl.2013.07.045  0.46
2013 Michopoulos V, Embree M, Reding K, Sanchez MM, Toufexis D, Votaw JR, Voll RJ, Goodman MM, Rivier J, Wilson ME, Berga SL. CRH receptor antagonism reverses the effect of social subordination upon central GABAA receptor binding in estradiol-treated ovariectomized female rhesus monkeys. Neuroscience. 250: 300-8. PMID 23856065 DOI: 10.1016/J.Neuroscience.2013.07.002  0.306
2013 Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR, Freeman AA, Rye DB, Goodman MM, Howell LL, Miller AH. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2179-87. PMID 23657438 DOI: 10.1038/Npp.2013.115  0.611
2013 Okudaira H, Nakanishi T, Oka S, Kobayashi M, Tamagami H, Schuster DM, Goodman MM, Shirakami Y, Tamai I, Kawai K. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. Nuclear Medicine and Biology. 40: 670-5. PMID 23647854 DOI: 10.1016/j.nucmedbio.2013.03.009  0.415
2013 Amzat R, Taleghani P, Miller DL, Beitler JJ, Bellamy LM, Nye JA, Yu W, Savir-Baruch B, Osunkoya AO, Chen Z, Auffermann WF, Goodman MM, Schuster DM. Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 633-43. PMID 23595643 DOI: 10.1007/S11307-012-0606-7  0.404
2013 Zeng F, Goodman MM. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease. Current Topics in Medicinal Chemistry. 13: 909-19. PMID 23590167 DOI: 10.2174/1568026611313080004  0.393
2013 Goodman MM, McConathy J. Fluorine-containing drugs as PET diagnostics (F-18 labeled tracers). Current Topics in Medicinal Chemistry. 13: 869-70. PMID 23590165 DOI: 10.2174/1568026611313080001  0.632
2013 Nye JA, Purselle D, Plisson C, Voll RJ, Stehouwer JS, Votaw JR, Kilts CD, Goodman MM, Nemeroff CB. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging. Depression and Anxiety. 30: 902-7. PMID 23526784 DOI: 10.1002/Da.22049  0.346
2013 Smith AL, Freeman SM, Voll RJ, Young LJ, Goodman MM. Carbon-11 N-methyl alkylation of L-368,899 and in vivo PET imaging investigations for neural oxytocin receptors. Bioorganic & Medicinal Chemistry Letters. 23: 902-6. PMID 23270988 DOI: 10.1016/J.Bmcl.2012.10.116  0.38
2012 Batis J, Barret O, Alagille D, Koren AO, Stehouwer JS, Cosgrove K, Goodman M, Seibyl J, Tamagnan G. In vivo evaluation of [¹²³I]mZIENT as a SPECT radioligand for the serotonin transporter. Nuclear Medicine and Biology. 39: 1137-41. PMID 23084043 DOI: 10.1016/J.Nucmedbio.2012.07.006  0.352
2012 Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ, Votaw JR, Goodman MM, Miller AH. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Archives of General Psychiatry. 69: 1044-53. PMID 23026954 DOI: 10.1001/archgenpsychiatry.2011.2094  0.341
2012 Dunlop BW, Binder EB, Cubells JF, Goodman MM, Kelley ME, Kinkead B, Kutner M, Nemeroff CB, Newport DJ, Owens MJ, Pace TW, Ritchie JC, Rivera VA, Westen D, Craighead WE, et al. Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials. 13: 106. PMID 22776534 DOI: 10.1186/1745-6215-13-106  0.466
2012 Sawyer EK, Mun J, Nye JA, Kimmel HL, Voll RJ, Stehouwer JS, Rice KC, Goodman MM, Howell LL. Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1816-24. PMID 22434223 DOI: 10.1038/Npp.2012.29  0.585
2012 Smith AL, Freeman SM, Stehouwer JS, Inoue K, Voll RJ, Young LJ, Goodman MM. Synthesis and evaluation of C-11, F-18 and I-125 small molecule radioligands for detecting oxytocin receptors. Bioorganic & Medicinal Chemistry. 20: 2721-38. PMID 22425346 DOI: 10.1016/J.Bmc.2012.02.019  0.445
2012 Nicol A, Krishnadas R, Champion S, Tamagnan G, Stehouwer JS, Goodman MM, Hadley DM, Pimlott SL. Biodistribution and dosimetry of ¹²³I-mZIENT: a novel ligand for imaging serotonin transporters. European Journal of Nuclear Medicine and Molecular Imaging. 39: 786-91. PMID 22302090 DOI: 10.1007/s00259-011-2056-x  0.38
2012 Kimmel HL, Nye JA, Voll R, Mun J, Stehouwer J, Goodman MM, Votaw JR, Carroll FI, Howell LL. Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeys. Synapse (New York, N.Y.). 66: 501-8. PMID 22237864 DOI: 10.1002/Syn.21536  0.622
2012 Oka S, Okudaira H, Yoshida Y, Schuster DM, Goodman MM, Shirakami Y. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells. Nuclear Medicine and Biology. 39: 109-19. PMID 21958853 DOI: 10.1016/j.nucmedbio.2011.06.008  0.348
2012 McConathy J, Yu W, Jarkas N, Seo W, Schuster DM, Goodman MM. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents. Medicinal Research Reviews. 32: 868-905. PMID 21793016 DOI: 10.1002/med.20250  0.641
2011 Liang Z, Cho HT, Williams L, Zhu A, Liang K, Huang K, Wu H, Jiang C, Hong S, Crowe R, Goodman MM, Shim H. Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression. Nuclear Medicine and Molecular Imaging. 45: 93-102. PMID 24899987 DOI: 10.1007/S13139-010-0068-2  0.312
2011 Amzat R, Taleghani P, Savir-Baruch B, Nieh PT, Master VA, Halkar RK, Lewis MM, Faurot M, Bellamy LM, Goodman MM, Schuster DM. Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT. Clinical Nuclear Medicine. 36: 800-2. PMID 21825855 DOI: 10.1097/RLU.0b013e318219b47e  0.34
2011 Nye JA, Jarkas N, Schuster DM, Savir-Baruch B, Voll RJ, Camp VM, Goodman MM. Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid. Nuclear Medicine and Biology. 38: 1035-41. PMID 21741251 DOI: 10.1016/J.Nucmedbio.2011.03.007  0.427
2011 Schuster DM, Savir-Baruch B, Nieh PT, Master VA, Halkar RK, Rossi PJ, Lewis MM, Nye JA, Yu W, Bowman FD, Goodman MM. Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. Radiology. 259: 852-61. PMID 21493787 DOI: 10.1148/Radiol.11102023  0.345
2011 Savir-Baruch B, Schuster DM, Jarkas N, Master VA, Nieh PT, Halkar RK, Nye JA, Lewis MM, Crowe RJ, Voll RJ, Camp VM, Bellamy LM, Roberts DL, Goodman MM. Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 1272-7. PMID 20976627 DOI: 10.1007/S11307-010-0445-3  0.398
2011 Zhu A, Yoon Y, Liang Z, Voll R, Goodman ME, Goodman MM, Shim H. Abstract 5227: Detection of metastatic potential by a novel small molecule F-18 PET imaging agent Cancer Research. 71: 5227-5227. DOI: 10.1158/1538-7445.Am2011-5227  0.416
2011 Krishnadas R, Nicol A, Champion S, Pimlott S, Stehouwer J, Tamagnan G, Goodman M, Hadley D. Spect imaging of the serotonin transporter using a novel ligand - 123-I mZIENT - in human subjects - a dosimetry and biodisortribution study European Psychiatry. 26: 935-935. DOI: 10.1016/S0924-9338(11)72640-2  0.376
2011 Felger J, Kimmel H, Hernandez C, Mun J, Nye J, Goodman M, Drake D, Freeman A, Rye D, Howell L, Miller A. 96. Chronic IFN-alpha administration reduces basal ganglia dopamine release in rhesus monkeys: Preliminary results from in vivo microdialysis and neuroimaging Brain, Behavior, and Immunity. 25: S206. DOI: 10.1016/J.Bbi.2011.07.099  0.572
2010 Zeng F, Alagille D, Tamagnan GD, Ciliax BJ, Levey AI, Goodman MM. Synthesis and In Vitro Evaluation of Imidazo[1,2-b]pyridazines as Ligands for β-Amyloid Plaques. Acs Medicinal Chemistry Letters. 1: 80-4. PMID 24900181 DOI: 10.1021/ml100005j  0.317
2010 Masilamoni G, Votaw J, Howell L, Villalba RM, Goodman M, Voll RJ, Stehouwer J, Wichmann T, Smith Y. (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism. Experimental Neurology. 226: 265-73. PMID 20832405 DOI: 10.1016/J.Expneurol.2010.08.024  0.424
2010 Jarkas N, Voll RJ, Williams L, Camp VM, Goodman MM. (R,S)-anti-1-amino-2-[18F]fluorocyclopentyl-1-carboxylic acid: synthesis from racemic 2-benzyloxycyclopentanone and biological evaluation for brain tumor imaging with positron emission tomography. Journal of Medicinal Chemistry. 53: 6603-7. PMID 20718421 DOI: 10.1021/jm100841m  0.41
2010 Jarkas N, Voll RJ, Williams L, Goodman MM. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET. Nuclear Medicine and Biology. 37: 593-603. PMID 20610164 DOI: 10.1016/j.nucmedbio.2010.03.004  0.404
2010 Cosgrove KP, Staley JK, Baldwin RM, Bois F, Plisson C, Al-Tikriti MS, Seibyl JP, Goodman MM, Tamagnan GD. SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain. Nuclear Medicine and Biology. 37: 587-91. PMID 20610163 DOI: 10.1016/j.nucmedbio.2010.03.007  0.382
2010 Stehouwer JS, Daniel LM, Chen P, Voll RJ, Williams L, Plott SJ, Votaw JR, Owens MJ, Howell L, Goodman MM. Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography. Journal of Medicinal Chemistry. 53: 5549-57. PMID 20597489 DOI: 10.1021/Jm100269C  0.656
2010 Yu W, Williams L, Camp VM, Olson JJ, Goodman MM. Synthesis and biological evaluation of anti-1-amino-2-[18F]fluoro-cyclobutyl-1-carboxylic acid (anti-2-[18F]FACBC) in rat 9L gliosarcoma. Bioorganic & Medicinal Chemistry Letters. 20: 2140-3. PMID 20207538 DOI: 10.1016/j.bmcl.2010.02.048  0.437
2010 Yu W, McConathy J, Williams L, Camp VM, Malveaux EJ, Zhang Z, Olson JJ, Goodman MM. Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors. Journal of Medicinal Chemistry. 53: 876-86. PMID 20028004 DOI: 10.1021/jm900556s  0.645
2010 Liang Z, Cho HT, Liang K, Zhu A, Huang K, Wu H, Hong S, Goodman MM, Shim H. Abstract 2736: Overexpression of L-type amino acid transporter-1 in breast cancer cells and tissues: potential association with growth and progression of tumors Cancer Research. 70: 2736-2736. DOI: 10.1158/1538-7445.Am10-2736  0.352
2010 Nye JA, Owens MJ, Dunlop BW, Jarkas N, Mayberg HS, Goodman MM. Test–retest reliability of the SERT imaging agent [11C]HOMADAM in healthy humans ☆ Neuroimage. 52. DOI: 10.1016/J.Neuroimage.2010.04.089  0.521
2009 Stehouwer JS, Goodman MM. Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine. Pet Clinics. 4: 101-128. PMID 20216936 DOI: 10.1016/j.cpet.2009.05.006  0.428
2009 Schuster DM, Nye JA, Nieh PT, Votaw JR, Halkar RK, Issa MM, Yu W, Sepulveda J, Zeng W, Young A, Goodman MM. Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 434-8. PMID 19449079 DOI: 10.1007/S11307-009-0220-5  0.345
2009 Fantegrossi WE, Bauzo RM, Manvich DM, Morales JC, Votaw JR, Goodman MM, Howell LL. Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates. Psychopharmacology. 205: 337-47. PMID 19421742 DOI: 10.1007/S00213-009-1545-0  0.33
2009 Yu W, Williams L, Camp VM, Malveaux E, Olson JJ, Goodman MM. Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent. Bioorganic & Medicinal Chemistry. 17: 1982-90. PMID 19216081 DOI: 10.1016/j.bmc.2009.01.032  0.451
2009 Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter. Journal of Medicinal Chemistry. 52: 62-73. PMID 19067522 DOI: 10.1021/Jm800817H  0.449
2008 Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM. Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. Journal of Medicinal Chemistry. 51: 7788-99. PMID 19053782 DOI: 10.1021/jm800781a  0.604
2008 Nye JA, Votaw JR, Jarkas N, Purselle D, Camp V, Bremner JD, Kilts CD, Nemeroff CB, Goodman MM. Compartmental modeling of 11C-HOMADAM binding to the serotonin transporter in the healthy human brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 2018-25. PMID 19038997 DOI: 10.2967/Jnumed.108.054262  0.327
2008 McConathy J, Goodman MM. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Reviews. 27: 555-73. PMID 18648909 DOI: 10.1007/s10555-008-9154-7  0.636
2008 Mun J, Wang Y, Voll RJ, Escuin-Borras D, Giannakakou P, Goodman MM. Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[(18)F]fluoroethoxyestradiol for positron emission tomography. Nuclear Medicine and Biology. 35: 615-22. PMID 18589306 DOI: 10.1016/J.Nucmedbio.2008.04.003  0.42
2008 Yu W, Wang E, Voll RJ, Miller AH, Goodman MM. Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor. Bioorganic & Medicinal Chemistry. 16: 6145-55. PMID 18472268 DOI: 10.1016/j.bmc.2008.04.046  0.358
2008 Kimmel HL, Negus SS, Wilcox KM, Ewing SB, Stehouwer J, Goodman MM, Votaw JR, Mello NK, Carroll FI, Howell LL. Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 90: 453-62. PMID 18468667 DOI: 10.1016/J.Pbb.2008.03.032  0.603
2008 Yu W, Williams L, Malveaux E, Camp VM, Olson JJ, Goodman MM. Synthesis and evaluation of [123I] labeled iodovinyl amino acids syn-, anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents. Bioorganic & Medicinal Chemistry Letters. 18: 1264-8. PMID 18258425 DOI: 10.1016/j.bmcl.2008.01.035  0.377
2008 Jarkas N, Voll RJ, Williams L, Votaw JR, Owens M, Goodman MM. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands. Journal of Medicinal Chemistry. 51: 271-81. PMID 18085744 DOI: 10.1021/jm0707929  0.587
2008 Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM. Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter. Bioorganic & Medicinal Chemistry. 16: 783-93. PMID 17983754 DOI: 10.1016/j.bmc.2007.10.025  0.637
2008 Yu W, Voll R, Miller A, Goodman M. Synthesis and in vitro evaluation of PK11195 analogue 1-(2-iodophenyl)-N-methyl-N-[18F]fluoropropyl-3-isoquinoline carboxamide as a potential peripheral benzodiazepine receptor radioligand Neuroimage. 41: T105. DOI: 10.1016/j.neuroimage.2008.04.074  0.339
2007 Yu W, McConathy J, Olson J, Camp VM, Goodman MM. Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography. Journal of Medicinal Chemistry. 50: 6718-21. PMID 18052089 DOI: 10.1021/jm070476u  0.619
2007 Plisson C, Stehouwer JS, Voll RJ, Howell L, Votaw JR, Owens MJ, Goodman MM. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent. Journal of Medicinal Chemistry. 50: 4553-60. PMID 17705359 DOI: 10.1021/jm061303s  0.597
2007 Nye JA, Schuster DM, Yu W, Camp VM, Goodman MM, Votaw JR. Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1017-20. PMID 17504867 DOI: 10.2967/Jnumed.107.040097  0.407
2007 Zeng F, Stehouwer JS, Jarkas N, Voll RJ, Williams L, Camp VM, Votaw JR, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM. Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents. Bioorganic & Medicinal Chemistry Letters. 17: 3044-7. PMID 17446069 DOI: 10.1016/j.bmcl.2007.03.056  0.601
2007 Howell LL, Carroll FI, Votaw JR, Goodman MM, Kimmel HL. Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 320: 757-65. PMID 17105829 DOI: 10.1124/Jpet.106.108324  0.607
2007 Tamagnan GD, Brenner E, Alagille D, Staley JK, Haile C, Koren A, Early M, Baldwin RM, Tarazi FI, Baldessarini RJ, Jarkas N, Goodman MM, Seibyl JP. Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. Bioorganic & Medicinal Chemistry Letters. 17: 533-7. PMID 17095215 DOI: 10.1016/j.bmcl.2006.10.018  0.359
2006 Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Owens MJ, Votaw JR, Goodman MM. Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. Journal of Medicinal Chemistry. 49: 6760-7. PMID 17154506 DOI: 10.1021/Jm060641Q  0.592
2006 Zeng F, Jarkas N, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM. Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position. Bioorganic & Medicinal Chemistry Letters. 16: 4661-3. PMID 16784855 DOI: 10.1016/j.bmcl.2006.05.098  0.551
2006 Zeng F, Southerland JA, Voll RJ, Votaw JR, Williams L, Ciliax BJ, Levey AI, Goodman MM. Synthesis and evaluation of two 18F-labeled imidazo[1,2-a]pyridine analogues as potential agents for imaging beta-amyloid in Alzheimer's disease. Bioorganic & Medicinal Chemistry Letters. 16: 3015-8. PMID 16574411 DOI: 10.1016/j.bmcl.2006.02.055  0.392
2006 Plisson C, Jarkas N, McConathy J, Voll RJ, Votaw J, Williams L, Howell LL, Kilts CD, Goodman MM. Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET. Journal of Medicinal Chemistry. 49: 942-6. PMID 16451060 DOI: 10.1021/Jm050799V  0.655
2006 Gilles T, Stehouwer J, Staley JK, Megyola C, Koren A, Goodman M, Seibyl J. In vivo characterization in subhuman primates of mZIENT: A new serotonin transporter, effects of selective SERT displacement Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.115  0.322
2006 Goodman M, Stehouwer J, Jarkas N, Voll R, Williams L, Votaw J. In vivo characterization in non-human primates of βFEmZIENT and βFEmZBrENT: New serotonin transporter imaging agents: effects of selective monoamine transporter displacement using microPET Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.017  0.355
2005 Stehouwer JS, Plisson C, Jarkas N, Zeng F, Voll RJ, Williams L, Martarello L, Votaw JR, Tamagnan G, Goodman MM. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 (N-fluoroalkyl) labeled 2beta-carbomethoxy-3beta-(4'-(3-furyl)phenyl)tropanes and -nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. Journal of Medicinal Chemistry. 48: 7080-3. PMID 16250668 DOI: 10.1021/jm0504095  0.425
2005 Wilcox KM, Kimmel HL, Lindsey KP, Votaw JR, Goodman MM, Howell LL. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys. Synapse (New York, N.Y.). 58: 220-8. PMID 16206183 DOI: 10.1002/Syn.20199  0.628
2005 McConathy J, Owens MJ, Kilts CD, Malveaux EJ, Votaw JR, Nemeroff CB, Goodman MM. Synthesis and biological evaluation of trans-3-phenyl-1-indanamines as potential norepinephrine transporter imaging agents. Nuclear Medicine and Biology. 32: 593-605. PMID 16026706 DOI: 10.1016/j.nucmedbio.2005.04.012  0.721
2005 Voll RJ, McConathy J, Waldrep MS, Crowe RJ, Goodman MM. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 63: 353-61. PMID 15985372 DOI: 10.1016/j.apradiso.2005.04.008  0.681
2005 Jarkas N, McConathy J, Voll RJ, Goodman MM. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands. Journal of Medicinal Chemistry. 48: 4254-65. PMID 15974579 DOI: 10.1021/jm050079o  0.617
2005 Jarkas N, Votaw JR, Voll RJ, Williams L, Camp VM, Owens MJ, Purselle DC, Bremner JD, Kilts CD, Nemeroff CB, Goodman MM. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters. Nuclear Medicine and Biology. 32: 211-24. PMID 15820756 DOI: 10.1016/j.nucmedbio.2004.11.007  0.609
2005 Ginsburg BC, Kimmel HL, Carroll FI, Goodman MM, Howell LL. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys. Pharmacology, Biochemistry, and Behavior. 80: 481-91. PMID 15740791 DOI: 10.1016/J.Pbb.2005.01.004  0.608
2005 Jarkas N, McConathy J, Votaw JR, Voll RJ, Malveaux E, Camp VM, Williams L, Goodman RR, Kilts CD, Goodman MM. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography. Nuclear Medicine and Biology. 32: 75-86. PMID 15691664 DOI: 10.1016/j.nucmedbio.2004.07.001  0.668
2004 Votaw JR, Byas-Smith MG, Voll R, Halkar R, Goodman MM. Isoflurane alters the amount of dopamine transporter expressed on the plasma membrane in humans. Anesthesiology. 101: 1128-35. PMID 15505448 DOI: 10.1097/00000542-200411000-00012  0.356
2004 McConathy J, Owens MJ, Kilts CD, Malveaux EJ, Camp VM, Votaw JR, Nemeroff CB, Goodman MM. Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter. Nuclear Medicine and Biology. 31: 705-18. PMID 15246361 DOI: 10.1016/j.nucmedbio.2003.05.001  0.726
2004 Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, Howell LL. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. The Journal of Pharmacology and Experimental Therapeutics. 309: 959-69. PMID 14982963 DOI: 10.1124/Jpet.103.060293  0.363
2004 Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter. Journal of Medicinal Chemistry. 47: 1122-35. PMID 14971892 DOI: 10.1021/jm030384e  0.637
2003 Byas-Smith M, Votaw J, Hua J, Voll R, Martarello L, Levey AI, Goodman M. Phenylephrine and norepinephrine increase dopamine transporter ligand binding in striatum. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 217-26. PMID 14499136 DOI: 10.1016/S1536-1632(03)00042-8  0.453
2003 McConathy J, Martarello L, Malveaux EJ, Camp VM, Simpson NE, Simpson CP, Bowers GD, Zhang Z, Olson JJ, Goodman MM. Synthesis and evaluation of 2-amino-4-[(18)F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids. Nuclear Medicine and Biology. 30: 477-90. PMID 12831985 DOI: 10.1016/S0969-8051(03)00025-8  0.666
2003 McConathy J, Voll RJ, Yu W, Crowe RJ, Goodman MM. Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 58: 657-66. PMID 12798374 DOI: 10.1016/S0969-8043(03)00029-0  0.651
2003 Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. Journal of Medicinal Chemistry. 46: 925-35. PMID 12620070 DOI: 10.1021/Jm0100180  0.638
2002 Martarello L, McConathy J, Camp VM, Malveaux EJ, Simpson NE, Simpson CP, Olson JJ, Bowers GD, Goodman MM. Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. Journal of Medicinal Chemistry. 45: 2250-9. PMID 12014963 DOI: 10.1021/jm010242p  0.663
2002 McConathy J, Martarello L, Malveaux EJ, Camp VM, Simpson NE, Simpson CP, Bowers GD, Olson JJ, Goodman MM. Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid. Journal of Medicinal Chemistry. 45: 2240-9. PMID 12014962 DOI: 10.1021/jm010241x  0.677
2002 Votaw JR, Howell LL, Martarello L, Hoffman JM, Kilts CD, Lindsey KP, Goodman MM. Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT. Synapse (New York, N.Y.). 44: 203-10. PMID 11984856 DOI: 10.1002/Syn.10068  0.369
2002 Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, Howell LL. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse (New York, N.Y.). 43: 78-85. PMID 11746736 DOI: 10.1002/Syn.10018  0.328
2001 McConathy J, Kilts CD, Goodman MM. Radioligands for PET and SPECT Imaging of the central noradrenergic system. Cns Spectrums. 6: 704-9. PMID 15520617 DOI: 10.1017/S1092852900001401  0.65
2001 Martarello L, Kilts CD, Ely T, Owens MJ, Nemeroff CB, Camp M, Goodman MM. Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor. Nuclear Medicine and Biology. 28: 187-95. PMID 11295429 DOI: 10.1016/S0969-8051(00)00199-2  0.541
2001 Jarkas N, Mcconathy J, Ely T, Kilts CD, Votaw J, Goodman MM. Synthesis and radiolabeling of new derivatives of adam, potential candidates as sert imaging agents for pet Journal of Labelled Compounds and Radiopharmaceuticals. 44: S204-S206. DOI: 10.1002/Jlcr.2580440171  0.631
2001 Martarello L, McConathy J, Camp M, Malveaux E, Olson J, Bowers G, Goodman MM. Synthesis and biological evaluation of syn and anti FMACBC, new amino acids for tumor imaging with PET Journal of Labelled Compounds and Radiopharmaceuticals. 44: S385-S387. DOI: 10.1002/JLCR.25804401136  0.641
2001 McConathy J, Martarello L, Goodman MM. Introduction of 18F at neopentyl positions via cyclic sulfamidates: Synthesis of 18F-labeled α, α-dialkyl amino acids as potential tumor imaging agents Journal of Labelled Compounds and Radiopharmaceuticals. 44: S376-S378. DOI: 10.1002/JLCR.25804401133  0.634
2000 Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, Votaw J, Ely TD, Lambert P, Owens MJ, Camp VM, Malveaux E, Hoffman JM. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nuclear Medicine and Biology. 27: 1-12. PMID 10755640 DOI: 10.1016/S0969-8051(99)00080-3  0.643
2000 Xing D, Chen P, Keil R, Kilts CD, Shi B, Camp VM, Malveaux G, Ely T, Owens MJ, Votaw J, Davis M, Hoffman JM, BaKay RA, Subramanian T, Watts RL, ... Goodman MM, et al. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography. Journal of Medicinal Chemistry. 43: 639-48. PMID 10691690 DOI: 10.1021/Jm9902234  0.603
2000 Martarello L, Kilts CD, Ely T, Owens MJ, Nemeroff CB, Goodman MM. Design, synthesis and evaluation of amino-anilino-pyramidines as potential spect ligands for the CRF1 receptor Psychoneuroendocrinology. 25: S37. DOI: 10.1016/S0306-4530(00)90130-6  0.506
1999 Shoup TM, Olson J, Hoffman JM, Votaw J, Eshima D, Eshima L, Camp VM, Stabin M, Votaw D, Goodman MM. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 40: 331-8. PMID 10025843  0.355
1999 Martarello L, Greenamyre JT, Goodman MM. Synthesis and evaluation of a new fluorine-18 labeled rotenoid as a potential pet probe of mitochondrial complex I activity Journal of Labelled Compounds and Radiopharmaceuticals. 42: 1039-1051. DOI: 10.1002/(SICI)1099-1344(199911)42:11<1039::AID-JLCR259>3.0.CO;2-1  0.399
1999 Shoup TM, Goodman MM. Synthesis of [F-18]-1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC): a PET tracer for tumor delineation Journal of Labelled Compounds and Radiopharmaceuticals. 42: 215-225. DOI: 10.1002/(SICI)1099-1344(199903)42:3<215::AID-JLCR180>3.0.CO;2-0  0.421
1998 Hoffman JM, Giroux M, Votaw JR, Kilts C, Martarello L, Votaw D, White M, Jones M, Watts RL, Goodman MM. Determination of Dopamine Transporter Density(DAT) in Humans with an 18F Labeled Nortropane(FECNT) and PET. Clinical Positron Imaging : Official Journal of the Institute For Clinical P.E.T. 1: 257. PMID 14516580 DOI: 10.1016/S1095-0397(98)00047-8  0.421
1998 Waterhouse RN, Gotsick JT, Kabalka GW, Goodman MM, O'Brien JC. In vivo evaluation of [123I]-8-[4-[2-(5-iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3 ,8-tri azaspiro[4.5]decan-4-one as a potential dopamine D2 receptor radioligand for SPECT. Nuclear Medicine and Biology. 25: 77-80. PMID 9466366 DOI: 10.1016/S0969-8051(97)00137-6  0.321
1998 Votaw JR, Deterding T, Hoffman JM, Kilts C, Votaw DB, Giroux M, Camp VM, Martarello L, Malveaux E, Goodman MM. Reproducibility of A BMAX Measure Using a NEW 18F Dopamine Transporter Ligand Neuroimage. 7. DOI: 10.1016/S1053-8119(18)31891-3  0.381
1997 Subramanian T, Emerich DF, Bakay RA, Hoffman JM, Goodman MM, Shoup TM, Miller GW, Levey AI, Hubert GW, Batchelor S, Winn SR, Saydoff JA, Watts RL. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplantation. 6: 469-77. PMID 9331498 DOI: 10.1016/S0963-6897(97)00049-3  0.355
1995 Kung MP, Essman WD, Frederick D, Meegalla S, Goodman M, Mu M, Lucki I, Kung HF. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse (New York, N.Y.). 20: 316-24. PMID 7482291 DOI: 10.1002/Syn.890200405  0.368
1989 Goodman MM, Knapp FF. Radioiodinated branched carbohydrates International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 16: i. DOI: 10.1016/0883-2897(89)90153-0  0.329
1986 Yamamoto K, Som P, Brill AB, Yonekura Y, Srivastava SC, Meinken GE, Iwai J, Goodman MM, Knapp FF, Elmaleh DR. Dual tracer autoradiographic study of beta-methyl-(1-14C) heptadecanoic acid and 15-p-(131I)-iodophenyl-beta-methylpentadecanoic acid in normotensive and hypertensive rats. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 27: 1178-83. PMID 3723193  0.574
1985 Livni E, Elmaleh DR, Barlai-Kovach MM, Goodman MM, Knapp FF, Strauss HW. Radioiodinated beta-methyl phenyl fatty acids as potential tracers for myocardial imaging and metabolism. European Heart Journal. 6: 85-9. PMID 4085510 DOI: 10.1093/Eurheartj/6.Suppl_B.85  0.569
1985 Okada RD, Knapp FF, Goodman MM, Elmaleh D, William Strauss H. Tellurium-labeled fatty-acid analogs: Relationship of heteroatom position to myocardial kinetics European Journal of Nuclear Medicine. 11: 156-161. PMID 4065154 DOI: 10.1007/BF00251366  0.533
1985 Goodman MM, Callahan AP, Knapp FF. Design, synthesis, and evaluation of omega-iodovinyl- and omega-iodoalkyl-substituted methyl-branched long-chain fatty acids. Journal of Medicinal Chemistry. 28: 807-15. PMID 4009604 DOI: 10.1021/jm00383a020  0.324
1985 Yonekura Y, Brill AB, Som P, Yamamoto K, Srivastava SC, Iwai J, Elmaleh DR, Livni E, Strauss HW, Goodman MM. Regional myocardial substrate uptake in hypertensive rats: a quantitative autoradiographic measurement. Science (New York, N.Y.). 227: 1494-6. PMID 3975623 DOI: 10.1126/science.3975623  0.537
1984 Kearfott KJ, Elmaleh DR, Goodman M, Correia JA, Alpert NM, Ackerman RH, Brownell GL, Strauss WH. Comparison of 2- and 3-18F-fluoro-deoxy-D-glucose for studies of tissue metabolism. International Journal of Nuclear Medicine and Biology. 11: 15-22. PMID 6610664 DOI: 10.1016/0047-0740(84)90023-8  0.603
1982 Goodman MM, Knapp FF, Callahan AP, Ferren LA. Synthesis and biological evaluation of 17-[131I]iodo-9-telluraheptadecanoic acid, a potential imaging agent. Journal of Medicinal Chemistry. 25: 613-8. PMID 7097713 DOI: 10.1021/JM00348A001  0.364
1981 Goodman MM, Elmaleh DR, Kearfott KJ, Ackerman RH, Hoop B, Brownell GL, Alpert NM, Strauss HW. F-18-labeled 3-deoxy-3-fluoro-D-glucose for the study of regional metabolism in the brain and heart. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 22: 138-44. PMID 6970254  0.588
1981 Goodman MM, Knapp FF, Strauss HW, Elmaleh DR, Kopiwoda SY, Callahan AP, Ferren LA. PROLONGED MYOCARDIAL RETENTION OF 15-PHENYL-5- TELLURAPENTADECANOIC ACID: A NEW AGENT FOR POTENTIAL LABELING WITH 1-123 Clinical Nuclear Medicine. 6: p157. DOI: 10.1097/00003072-198110001-00064  0.578
1977 Goodman MM, Paudler WW. 3-Azido-1,2,4-triazineN-Oxides. Syntheses and structure elucidation Journal of Heterocyclic Chemistry. 14: 1221-1223. DOI: 10.1002/JHET.5570140718  0.558
1976 GOODMAN MM, ATWOOD JL, CARLIN R, HUNTER W, PAUDLER WW. ChemInform Abstract: TETRAZOLO(1,5-B)-1,2,4-TRIAZINES. SYNTHESES AND STRUCTURE DETERMINATION Chemischer Informationsdienst. 7: no-no. DOI: 10.1002/Chin.197647280  0.532
Show low-probability matches.